Clinical outcome in Chinese patients with long lesion or small vessel / multi-vessel disease receiving XIENCE V everolimus-eluting stent: 30-day results from the SEEDS study

724

  • Xu, Bo
  • Yang, Yuejin
  • Han, Yaling
  • Li, Bao
  • Liu, Qiang
  • Zhu, Guoying
  • Cui, Junyu
  • Li, Lang
  • Lu, Shuzheng

  • 1.State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China

    2.The General Hospital of Shengyang Military Region, Shengyang 110016, China

    3.Shanxi Cardiovascular Hosptial, Taiyuan 030024, China

    4.Shenzhen Sun Yat-Sen Cardiovascular Hospital, Guangdong Province, Shenzhen 518000, China

    5.Wuhan Asia Heart Hospital, Wuhan 430022, China

    6.PLA the Military General Hospital of Beijing, Beijing 100700, China

    7.First Affiliated Hospital of Guangxi Medical University, Guangxi 530021, China

    8.Beijing Anzhen Hospital, Beijing 100029, China

Cardiology 123:p 171-172, August 2013.
Copyright © 2013 S. Karger AG, Basel